AddLife acquires Norwegian Hepro Group – leader in home care products and welfare technology

22.02.2017 - 10:30

AddLife signed an agreement today for the acquisition of all shares in the three companies of the Hepro Group: Hepro AS, Mektron AS and Hepro Sverige AB. The Hepro Group develops, designs and markets assistive technology within home care and welfare technology. These products facilitate health care and social services in the home, a market undergoing strong growth. The acquisitions will be a positive addition to the other companies in AddLife’s Medtech business area.
-“With a growing and aging population throughout the Nordic region, there is a strong need for assistive equipment for home care, and it is only expected to grow stronger. The acquisition involves functional products and digital welfare technology that will provide greater independence, activity and security for people with disabilities”, says Kristina Willgård, CEO, AddLife.

The Hepro Group is successfully positioned in the Norwegian market as one of the leading companies in home care and welfare technology. The companies' products and solutions are currently sold primarily to public sector and private healthcare players, with some sales directly to the end consumer. The companies have 40 employees and sales of NOK 155 million, mainly in the Norwegian market.

The acquisitions represent a strategic entry for AddLife in the field of home care in Norway, while laying the foundation for continued expansion in an attractive growth area. The acquisitions are also an excellent addition to Svan Care AB, a company acquired in October 2016. The Hepro Group markets parts of Svan Care AB’s line of products on the Norwegian market, while Svan Care AB markets parts of the Hepro Group’s line of products on the Swedish market.

Ownership will come effective on 1 March 2017. The acquisition is expected to have a marginally positive effect on AddLife’s earnings per share during the current financial year.

Stockholm, 22 February 2017

AddLife AB (publ.)
For more information, please contact
Kristina Willgård, CEO, AddLife AB, +46 705 10 12 23
Lars-Erik Rydell, business area manager of Medtech, AddLife AB, +46 709 46 48 77

AddLife is an independent player in the Life Science sector, offering high-quality products, services and advice to the private and public sectors, above all in the Nordic region. AddLife has about 550 employees in some 30 subsidiaries that operate under their own brands. The Group has annual sales of about SEK 1.9 billion. The AddLife share is listed on Nasdaq Stockholm.

This information is information that AddLife AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 10:30 a.m. CET on 22 February 2017.